Cargando…

Use of Drugs with Anticholinergic Properties at Hospital Admission Associated with Mortality in Older Patients: A Danish Nationwide Register-Based Cohort Study

BACKGROUND: Use of drugs with anticholinergic properties (DAP) has a negative impact on older people. OBJECTIVE: Our aim was to examine the association between DAP at hospital admission and mortality in older patients. PATIENTS AND METHODS: We performed a nationwide population-based cohort study inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Sørensen, Søren Ramsdal, Frederiksen, Jeppe Dalskov, Anru, Pavithra Laxsen, Masud, Tahir, Petrovic, Mirko, Rosholm, Jens-Ulrik, Ryg, Jesper
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844340/
https://www.ncbi.nlm.nih.gov/pubmed/34414558
http://dx.doi.org/10.1007/s40801-021-00270-7
_version_ 1784651451993161728
author Sørensen, Søren Ramsdal
Frederiksen, Jeppe Dalskov
Anru, Pavithra Laxsen
Masud, Tahir
Petrovic, Mirko
Rosholm, Jens-Ulrik
Ryg, Jesper
author_facet Sørensen, Søren Ramsdal
Frederiksen, Jeppe Dalskov
Anru, Pavithra Laxsen
Masud, Tahir
Petrovic, Mirko
Rosholm, Jens-Ulrik
Ryg, Jesper
author_sort Sørensen, Søren Ramsdal
collection PubMed
description BACKGROUND: Use of drugs with anticholinergic properties (DAP) has a negative impact on older people. OBJECTIVE: Our aim was to examine the association between DAP at hospital admission and mortality in older patients. PATIENTS AND METHODS: We performed a nationwide population-based cohort study including patients aged ≥ 65 years admitted to Danish geriatric medicine departments during 2005–2014. National health registers were used to link with individual-level data. Patients were followed to emigration, death, or study termination (31 December 2015). DAP was defined as medications included in the anticholinergic cognitive burden (ACB) scale, which assigns each DAP a score between 1 and 3. The individual ACB score was calculated and the number of DAP counted. We used Cox proportional-hazard regressions to estimate the crude and adjusted hazard ratios adjusting for age, activities of daily living, marital status, index admission period, BMI, and prior hospitalizations (model 1), and additionally Charlson Comorbidity Index (model 2). RESULTS: We included 74,589 patients aged (median [IQR]) 83 (77–88) years. Use of one or more DAP (62.5%) was associated with increased mortality compared with those with no use (p < 0.001). In the fully adjusted model 2, compared with no use, higher mortality risks (HR [95% CI]) were seen with ACB score of 2 and number of DAP ≥ 5 for 30-day (1.46 [1.32–1.61] and 1.46 [1.09–1.95]), 1-year (1.34 [1.28–1.41] and 1.48 [1.29–1.70]), and overall mortality (1.27 [1.23–1.31] and 1.44 [1.31–1.59]), respectively. CONCLUSIONS: Use of DAP at hospital admission is associated with short- and long-term mortality in geriatric patients. Deprescribing studies are warranted to study whether the impact on mortality can be attenuated. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40801-021-00270-7.
format Online
Article
Text
id pubmed-8844340
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-88443402022-02-23 Use of Drugs with Anticholinergic Properties at Hospital Admission Associated with Mortality in Older Patients: A Danish Nationwide Register-Based Cohort Study Sørensen, Søren Ramsdal Frederiksen, Jeppe Dalskov Anru, Pavithra Laxsen Masud, Tahir Petrovic, Mirko Rosholm, Jens-Ulrik Ryg, Jesper Drugs Real World Outcomes Original Research Article BACKGROUND: Use of drugs with anticholinergic properties (DAP) has a negative impact on older people. OBJECTIVE: Our aim was to examine the association between DAP at hospital admission and mortality in older patients. PATIENTS AND METHODS: We performed a nationwide population-based cohort study including patients aged ≥ 65 years admitted to Danish geriatric medicine departments during 2005–2014. National health registers were used to link with individual-level data. Patients were followed to emigration, death, or study termination (31 December 2015). DAP was defined as medications included in the anticholinergic cognitive burden (ACB) scale, which assigns each DAP a score between 1 and 3. The individual ACB score was calculated and the number of DAP counted. We used Cox proportional-hazard regressions to estimate the crude and adjusted hazard ratios adjusting for age, activities of daily living, marital status, index admission period, BMI, and prior hospitalizations (model 1), and additionally Charlson Comorbidity Index (model 2). RESULTS: We included 74,589 patients aged (median [IQR]) 83 (77–88) years. Use of one or more DAP (62.5%) was associated with increased mortality compared with those with no use (p < 0.001). In the fully adjusted model 2, compared with no use, higher mortality risks (HR [95% CI]) were seen with ACB score of 2 and number of DAP ≥ 5 for 30-day (1.46 [1.32–1.61] and 1.46 [1.09–1.95]), 1-year (1.34 [1.28–1.41] and 1.48 [1.29–1.70]), and overall mortality (1.27 [1.23–1.31] and 1.44 [1.31–1.59]), respectively. CONCLUSIONS: Use of DAP at hospital admission is associated with short- and long-term mortality in geriatric patients. Deprescribing studies are warranted to study whether the impact on mortality can be attenuated. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40801-021-00270-7. Springer International Publishing 2021-08-19 /pmc/articles/PMC8844340/ /pubmed/34414558 http://dx.doi.org/10.1007/s40801-021-00270-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research Article
Sørensen, Søren Ramsdal
Frederiksen, Jeppe Dalskov
Anru, Pavithra Laxsen
Masud, Tahir
Petrovic, Mirko
Rosholm, Jens-Ulrik
Ryg, Jesper
Use of Drugs with Anticholinergic Properties at Hospital Admission Associated with Mortality in Older Patients: A Danish Nationwide Register-Based Cohort Study
title Use of Drugs with Anticholinergic Properties at Hospital Admission Associated with Mortality in Older Patients: A Danish Nationwide Register-Based Cohort Study
title_full Use of Drugs with Anticholinergic Properties at Hospital Admission Associated with Mortality in Older Patients: A Danish Nationwide Register-Based Cohort Study
title_fullStr Use of Drugs with Anticholinergic Properties at Hospital Admission Associated with Mortality in Older Patients: A Danish Nationwide Register-Based Cohort Study
title_full_unstemmed Use of Drugs with Anticholinergic Properties at Hospital Admission Associated with Mortality in Older Patients: A Danish Nationwide Register-Based Cohort Study
title_short Use of Drugs with Anticholinergic Properties at Hospital Admission Associated with Mortality in Older Patients: A Danish Nationwide Register-Based Cohort Study
title_sort use of drugs with anticholinergic properties at hospital admission associated with mortality in older patients: a danish nationwide register-based cohort study
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844340/
https://www.ncbi.nlm.nih.gov/pubmed/34414558
http://dx.doi.org/10.1007/s40801-021-00270-7
work_keys_str_mv AT sørensensørenramsdal useofdrugswithanticholinergicpropertiesathospitaladmissionassociatedwithmortalityinolderpatientsadanishnationwideregisterbasedcohortstudy
AT frederiksenjeppedalskov useofdrugswithanticholinergicpropertiesathospitaladmissionassociatedwithmortalityinolderpatientsadanishnationwideregisterbasedcohortstudy
AT anrupavithralaxsen useofdrugswithanticholinergicpropertiesathospitaladmissionassociatedwithmortalityinolderpatientsadanishnationwideregisterbasedcohortstudy
AT masudtahir useofdrugswithanticholinergicpropertiesathospitaladmissionassociatedwithmortalityinolderpatientsadanishnationwideregisterbasedcohortstudy
AT petrovicmirko useofdrugswithanticholinergicpropertiesathospitaladmissionassociatedwithmortalityinolderpatientsadanishnationwideregisterbasedcohortstudy
AT rosholmjensulrik useofdrugswithanticholinergicpropertiesathospitaladmissionassociatedwithmortalityinolderpatientsadanishnationwideregisterbasedcohortstudy
AT rygjesper useofdrugswithanticholinergicpropertiesathospitaladmissionassociatedwithmortalityinolderpatientsadanishnationwideregisterbasedcohortstudy